Detalhe da pesquisa
1.
Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma.
Gut
; 68(11): 1918-1927, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30852560
2.
Pathologic Lymph Node Regression After Neoadjuvant Chemotherapy Predicts Recurrence and Survival in Esophageal Adenocarcinoma: A Multicenter Study in the United Kingdom.
J Clin Oncol
; 41(28): 4522-4534, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37499209
3.
Identification of Src as a Therapeutic Target in Oesophageal Adenocarcinoma through Functional Genomic and High-Throughput Drug Screening Approaches.
Cancers (Basel)
; 14(15)2022 Jul 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35954391